EUROPEAN JOURNAL OF HEALTH LAW最新文献_第7页

The Conceptual Legal Structure of The Patient's Right to Informed Consent. 患者知情同意权的概念法律结构。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-05-12 DOI: 10.1163/15718093-bja10087

Noelia Martínez-Doallo

引用次数: 0

Women's Birthing Bodies and the Law: Unauthorised Intimate Examinations, Power and Vulnerability, edited by Camilla Pickles and John Herring. 《妇女分娩的身体和法律:未经授权的亲密检查、权力和脆弱》，卡米拉·皮克尔斯和约翰·赫林主编。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-05-06 DOI: 10.1163/15718093-bja10088

Emma Milne

引用次数: 0

European Court of Justice. 欧洲法院。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-18 DOI: 10.1163/15718093-12423548

A. Baeyens

引用次数: 0

The European Court of Human Rights and the Emergence of Human Germline Genome Editing. 欧洲人权法院与人类生殖系基因组编辑的出现。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-13 DOI: 10.1163/15718093-bja10082

Merel M Spaander

引用次数: 0

Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives. 管理、保护和调节基因组编辑的未来:ELSPI观点的意义。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-08 DOI: 10.1163/15718093-bja10076

Santa Slokenberga, Timo Minssen, Ana Nordberg

引用次数: 1

Addressing Cognitive Vulnerabilities through Genome and Epigenome Editing: Techno-Legal Adaptations for Persons with Intellectual Disabilities. 通过基因组和表观基因组编辑解决认知脆弱性:智障人士的技术法律适应。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-08 DOI: 10.1163/15718093-bja10085

Pin Lean Lau

{"title":"Addressing Cognitive Vulnerabilities through Genome and Epigenome Editing: Techno-Legal Adaptations for Persons with Intellectual Disabilities.","authors":"Pin Lean Lau","doi":"10.1163/15718093-bja10085","DOIUrl":"https://doi.org/10.1163/15718093-bja10085","url":null,"abstract":"The key aim of this paper is to highlight the oft-under-represented narrative of how persons with disabilities (specifically, those with intellectual disabilities) may access the benefits that genome editing may offer. Firstly, this paper reflects on the critical need for a paradigm shift in how we view intellectual disabilities, and centering the rights of persons with disabilities to allow them to access the broad scope of their right to health under various international law instruments (including the complementary right to habilitation under Article 26 of the CRPD). Secondly, the paper evaluates the legal provisions in the CRPD and other international instruments relating to the rights of persons with intellectual disabilities, and their access to genome editing technologies. This analysis intends to demonstrate that human rights in disability discourse be complemented with emancipatory, participatory, and transformative research. Finally, the paper argues for a reinvigorated line of thinking that expands on the social model of disability: to align with inclusive, contemporary disability discourse that embodies greater responsibility and innovation in perpetuating better access to genome editing technologies for persons with intellectual disabilities.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 3-5","pages":"409-434"},"PeriodicalIF":0.8,"publicationDate":"2022-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10022045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law. 平衡人类生殖系编辑中的创新、“公共秩序”和道德:呼吁在专利法中采取更细致入微的方法。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-08 DOI: 10.1163/15718093-bja10073

Duncan Matthews, Timo Minssen, Ana Nordberg

{"title":"Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law.","authors":"Duncan Matthews, Timo Minssen, Ana Nordberg","doi":"10.1163/15718093-bja10073","DOIUrl":"https://doi.org/10.1163/15718093-bja10073","url":null,"abstract":"This article analyses the role that 'ordre public' and morality exceptions can play in the granting of patents on inventions in the field of human germline editing and the consequences of this policy option. In order to provide the context for such an analysis, the article will, first, provide an overview of the current patent landscape for relevant genome editing technologies, drawing attention to recent patent disputes and, second, examine 'ordre public' and morality exceptions under patent law in international, national and regional law, and the implications for innovation and access to novel treatments. The article argues that patent exceptions should not be used as a blunt policy instrument, nor interpreted in a way that is contrary to the patent system's overall objectives. The 'ordre public' and morality based exceptions in the context of human germline editing should not be interpreted and applied in a way which results in outcomes counterproductive to the goal of balancing innovation with the protection of societal higher normative values. Instead, the application of the exception should be based on a sound understanding of both the underlying science as well as the broader ethical, social, and legal implications, thus enabling case-by-case decisions that provide the basis for patent claim amendments and nuanced purpose-bound protection. Further analysis and debate as to the role that such flexibilities can play in the context of genome editing technologies is therefore both necessary and desirable, and can be facilitated in the ways set out in this article.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 3-5","pages":"562-588"},"PeriodicalIF":0.8,"publicationDate":"2022-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10019387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

What Would It Take to Enable Germline Editing in Europe for Medical Purposes? 为了医学目的，在欧洲进行生殖细胞编辑需要什么?

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-08 DOI: 10.1163/15718093-bja10074

Santa Slokenberga

{"title":"What Would It Take to Enable Germline Editing in Europe for Medical Purposes?","authors":"Santa Slokenberga","doi":"10.1163/15718093-bja10074","DOIUrl":"https://doi.org/10.1163/15718093-bja10074","url":null,"abstract":"Commonly, the regulation on germline editing in Europe is described through the two prohibitions: the prohibition set out in Article 13 of the Convention for the protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine and the prohibition that is set out in the EU Clinical Trials Regulation. These prohibitions reflect the European regional position regarding the ethical and legal questions raised by the technology, and an unwillingness to enable such interventions in Europe. Simultaneously, these prohibitions have been shaped prior to the recent breakthroughs in the field, such as the discovery of the CRISPR-Cas technology, which has initiated a new era in the field. This contribution examines what it would take to enable human germline gene editing in Europe for medical purposes. It scrutinises in detail the content and context of the existing bans, as well as mechanisms to lift them. It argues that the bans that are prescribed by each of the European regional legal orders are embedded in strong structures, composed of values and principles. For the human germline gene editing to be enabled in Europe for health-related purposes, the approach to these values and principles needs to change. Only then can the machinery to lift the bans lead to a change.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 3-5","pages":"521-542"},"PeriodicalIF":0.8,"publicationDate":"2022-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10022041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Genetics and Justice, Non-Ideal Theory and the Role of Patents: The Case of CRISPR-Cas9. 遗传学与正义，非理想理论和专利的作用:以CRISPR-Cas9为例。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-08 DOI: 10.1163/15718093-bja10075

Oliver Feeney

引用次数: 0

A Room with a View (and with a Gene Therapy Drug): Gene Therapy Medicinal Products and Genetic Tourism in Europe. 一间有景观的房间(和一种基因治疗药物):欧洲的基因治疗药物产品和基因旅游。

IF 0.8

EUROPEAN JOURNAL OF HEALTH LAW Pub Date : 2022-04-08 DOI: 10.1163/15718093-bja10083

Vera Lúcia Raposo

引用次数: 0